ResearcherMassachusetts Institute of TechnologyActive in the last 2 years
Alexander Muir
Matched on ORCID iD 0000-0003-3811-3054; OpenAlex author ID A5090228463; NIH RePORTER profile ID 9849187. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 0, last author 1)
- Trials
- 0
- Grants
- 3
- Labs led
- 1
- Collaborators
- 68
2018: 1 paper, 1 grant · 2019: none · 2020: 1 grant · 2021: none · 2022: 1 paper · 2023: 2 papers · 2024: 1 paper · 2025: 1 paper · 2026: 3 papers, 1 grant
Papers 9
- Tissue-specific tolerance mechanisms and lymph node co-drainage shape T cell immunity in the upper digestive system and pancreatic cancer progression. Co-author DOI 10.1016/j.celrep.2026.117324↗
- The HIF-2 transcription factor mediates resistance to ferroptosis in pancreatic cancer. Co-author DOI 10.1016/j.molcel.2026.03.007↗
- Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. Co-author DOI 10.1053/j.gastro.2026.09.027↗
- Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancer Last author DOI 10.1101/2025.09.04.673818↗
- Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. Co-author DOI 10.1158/2159-8290.cd-23-0240↗
- Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. Co-author DOI 10.1016/j.xpro.2023.102711↗
- Uridine-derived ribose fuels glucose-restricted pancreatic cancer. Co-author DOI 10.1038/s41586-023-06073-w↗
- Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Cancer. Co-author DOI 10.1158/0008-5472.can-22-0431↗
- Altered exocrine function can drive adipose wasting in early pancreatic cancer. Co-author DOI 10.1038/s41586-018-0235-7↗
Grants 3
- Targeting nutrient microenvironment imprinted therapy resistance in pancreatic cancer R01CA276461↗
- Microenvironment Induced Metabolic Requirements of Pancreatic Cancers AWARD pancan:2020-alexander-muir-phd-microenvironment-induced-metabolic-requi
- Understanding metabolic pathways that support redox homeostasis in cancer F32CA213810↗
Closest collaborators
The 25 strongest of 68 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Colin S. Sheehan · 3 shared papers, 2022–2026 · strength 0.59
- Paper Tissue-specific tolerance mechanisms and lymph node co-drainage shape T cell immunity in the upper digestive system and… DOI 10.1016/j.celrep.2026.117324↗
- Paper Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancer DOI 10.1101/2025.09.04.673818↗
- Paper Bcl-xL Enforces a Slow-Cycling State Necessary for Survival in the Nutrient-Deprived Microenvironment of Pancreatic Can… DOI 10.1158/0008-5472.can-22-0431↗
- Christopher J. Halbrook · 3 shared papers, 2023–2026 · strength 0.51
- Paper Mevalonate Biosynthesis is a Metabolic Vulnerability of Gemcitabine-resistant Pancreatic Cancer. DOI 10.1053/j.gastro.2026.09.027↗
- Paper Tumor nutrient stress gives rise to a drug tolerant cell state in pancreatic cancer DOI 10.1101/2025.09.04.673818↗
- Paper Uridine-derived ribose fuels glucose-restricted pancreatic cancer. DOI 10.1038/s41586-023-06073-w↗
- Maimon E. Hubbi · 2 shared papers, 2022–2026 · strength 0.41
- Ben Z. Stanger · 2 shared papers, 2022–2026 · strength 0.41
- Chi Van Dang · 2 shared papers, 2022–2026 · strength 0.41
- Amanda R. Decker-Farrell · 2 shared papers, 2023–2024 · strength 0.40
- Paper Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. DOI 10.1016/j.xpro.2023.102711↗
- Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
- Kenneth P. Olive · 2 shared papers, 2023–2024 · strength 0.40
- Paper Generation and ex vivo culture of murine and human pancreatic ductal adenocarcinoma tissue slice explants. DOI 10.1016/j.xpro.2023.102711↗
- Paper Tumor Explants Elucidate a Cascade of Paracrine SHH, WNT, and VEGF Signals Driving Pancreatic Cancer Angiosuppression. DOI 10.1158/2159-8290.cd-23-0240↗
- Alica K. Michels · 2 shared papers, 2025–2026 · strength 0.39
- Erin Elizabeth Hollander · 1 shared paper, 2026 · strength 0.29
- Daria Esterhazy · 1 shared paper, 2026 · strength 0.28
- Macy Rae Komnick · 1 shared paper, 2026 · strength 0.28
- Yixuan D. Zhou · 1 shared paper, 2026 · strength 0.28
- Jennifer Brooke Valerin · 1 shared paper, 2026 · strength 0.20
- Chantal Allgöwer · 1 shared paper, 2026 · strength 0.20
- Austin D. Silva · 1 shared paper, 2026 · strength 0.20
- Tim Eiseler · 1 shared paper, 2026 · strength 0.20
- Rima Singh · 1 shared paper, 2026 · strength 0.20
- Kevin Christian Montecillo Gulay · 1 shared paper, 2026 · strength 0.20
- Alexander Kleger · 1 shared paper, 2026 · strength 0.20
- Thomas Theodor Werner Seufferlein · 1 shared paper, 2026 · strength 0.20
- Aimee L Edinger · 1 shared paper, 2026 · strength 0.20
- David Kuang-Fu Chang · 1 shared paper, 2026 · strength 0.20
- Hervé Tiriac · 1 shared paper, 2026 · strength 0.20
- Kay F. Macleod · 1 shared paper, 2025 · strength 0.19
- Leah Marie Ziolkowski · 1 shared paper, 2025 · strength 0.19
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.